Spago Nanomedical AB (publ) (FRA:7UX)
Germany · Delayed Price · Currency is EUR 0.0076
-0.0004 (-5.00%)
At close: Nov 21, 2025
Spago Nanomedical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 1.05 | 1.91 | 1.2 | 4.75 | 4.92 | 6.11 | Upgrade |
Other Revenue | 4.79 | 4.74 | 4.44 | 1.46 | 1.57 | 1.05 | Upgrade |
| 5.84 | 6.65 | 5.64 | 6.2 | 6.48 | 7.16 | Upgrade | |
Revenue Growth (YoY) | -16.35% | 17.94% | -9.06% | -4.30% | -9.48% | -62.23% | Upgrade |
Cost of Revenue | 12.15 | 14.27 | 24.49 | 20.35 | 21.69 | 6.53 | Upgrade |
Gross Profit | -6.31 | -7.62 | -18.84 | -14.15 | -15.21 | 0.63 | Upgrade |
Selling, General & Admin | 22.15 | 25.71 | 23.67 | 24.84 | 23.53 | 19.31 | Upgrade |
Other Operating Expenses | -0.06 | -0.26 | -0.29 | -0.26 | -0.05 | -0.08 | Upgrade |
Operating Expenses | 22.31 | 25.76 | 23.66 | 24.94 | 23.86 | 19.59 | Upgrade |
Operating Income | -28.61 | -33.38 | -42.51 | -39.09 | -39.07 | -18.95 | Upgrade |
Interest Expense | -0.12 | - | - | - | - | - | Upgrade |
Interest & Investment Income | 0.57 | 1.2 | 0.85 | 0.27 | 0.12 | 0.03 | Upgrade |
Currency Exchange Gain (Loss) | -0.33 | -0.33 | -0.57 | -0.38 | -0.13 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | - | - | 0 | -0 | Upgrade |
EBT Excluding Unusual Items | -28.49 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade |
Pretax Income | -28.49 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade |
Earnings From Continuing Operations | -28.49 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade |
Net Income | -28.49 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade |
Net Income to Common | -28.49 | -32.51 | -42.22 | -39.2 | -39.07 | -18.93 | Upgrade |
Shares Outstanding (Basic) | 348 | 295 | 98 | 64 | 39 | 27 | Upgrade |
Shares Outstanding (Diluted) | 348 | 295 | 98 | 64 | 39 | 27 | Upgrade |
Shares Change (YoY) | 46.37% | 201.51% | 52.68% | 62.83% | 45.01% | 35.32% | Upgrade |
EPS (Basic) | -0.08 | -0.11 | -0.43 | -0.61 | -0.99 | -0.70 | Upgrade |
EPS (Diluted) | -0.08 | -0.11 | -0.43 | -0.61 | -0.99 | -0.70 | Upgrade |
Free Cash Flow | -29.74 | -34.9 | -45.06 | -38.32 | -35.94 | -19.38 | Upgrade |
Free Cash Flow Per Share | -0.09 | -0.12 | -0.46 | -0.60 | -0.91 | -0.71 | Upgrade |
Gross Margin | -107.93% | -114.44% | - | -228.06% | -234.58% | 8.82% | Upgrade |
Operating Margin | -489.76% | -501.64% | -753.37% | -630.00% | -602.61% | -264.65% | Upgrade |
Profit Margin | -487.74% | -488.56% | -748.37% | -631.80% | -602.67% | -264.28% | Upgrade |
Free Cash Flow Margin | -509.14% | -524.45% | -798.69% | -617.68% | -554.40% | -270.57% | Upgrade |
EBITDA | -28.39 | -33.07 | -42.22 | -38.73 | -38.69 | -18.59 | Upgrade |
EBITDA Margin | - | - | - | - | - | -259.59% | Upgrade |
D&A For EBITDA | 0.22 | 0.31 | 0.28 | 0.36 | 0.38 | 0.36 | Upgrade |
EBIT | -28.61 | -33.38 | -42.51 | -39.09 | -39.07 | -18.95 | Upgrade |
EBIT Margin | - | - | - | - | - | -264.65% | Upgrade |
Revenue as Reported | 6.1 | 6.91 | 5.93 | 6.46 | 6.53 | 7.25 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.